To conclude, in this study, we have demonstrated for the first time that FOXM1 has a crucial role in 5-FU drug resistance in colon cancer cells, through regulating some of the main 5-FU targets, including TYMS, TK-1 and TYMP. Here, TK1 is linked to malignant colon neoplasm.